Early Intervention With Vedolizumab on Longer Term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-term Safety Programs.

Date publication

juillet 2020

Journal

Journal of Crohn's & colitis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Dulai PS, Peyrin-Biroulet L, Demuth D, Lasch K, Hahn KA, Lindner D, Patel H, Jairath V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32691844

Résumé

Crohn's disease (CD) is a chronic inflammatory bowel disease that, with progression, may require surgical intervention.

Mots clés

Crohn disease, therapy, vedolizumab

Référence

J Crohns Colitis. 2020 Jul 21;: